OSR HEALTH, INC. Noncash or Part Noncash Acquisition, Payables Assumed
OSR HEALTH, INC. (OSRH) reported Noncash or Part Noncash Acquisition, Payables Assumed of $362.32 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2025-04-22
- OSR HEALTH, INC. noncash or part noncash acquisition, payables assumed for fiscal 2024 was $362.32K, a 0.66% increase from fiscal 2023.
- OSR HEALTH, INC. noncash or part noncash acquisition, payables assumed for fiscal 2023 was $359.96K.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 12 month |
|---|---|
| 2024-12-31 | $362.32K 10-K · filed 2025-04-22 |
| 2023-12-31 | $359.96K 10-K · filed 2025-04-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |